Skip to main content
Fig. 3 | Cardiovascular Diabetology

Fig. 3

From: Efficacy and safety of sodium-glucose cotransporter 2 inhibitors initiation in patients with acute heart failure, with and without type 2 diabetes: a systematic review and meta-analysis

Fig. 3

Forest plots examining the efficacy endpoints of sodium-glucose cotransporter 2 inhibitors initiation in patients with acute heart failure. Events in the analyses represent total number of events rather than time-to-event endpoint data. SGLT2: sodium-glucose cotransporter 2; HF: heart failure; KCCQ: Kansas City Cardiomyopathy Questionnaire; M–H: Mantel–Haenszel; CI: confidence interval

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840